Mar 14, 2023 / 06:00PM GMT
Shaymus Contorno - Oppenheimer & Co. Inc. - Analyst
Good afternoon, and welcome to the next session of Oppenheimer's Annual Healthcare Conference. I'm Shaymus Contorno from the medtech research team. Next up, we're pleased to have CEO, Phil Toleikis, from Sernova for a presentation.
With that, I'll turn it over to you Phil. I'll resurface with about five minutes left for some Q&A. And, to you.
Phil Toleikis - Sernova Corp. - President & CEO
Thank you very much and good to be here today. So Sernova is a cell therapeutics company, and we're at the clinical stage. And our goal is to provide functional cures for a number of chronic serious diseases. We are listed on the Toronto Stock Exchange under the symbol SVA, where most of our shares are trading. But we're also on the OTCQB under the symbol SEOVF. And we have aspirations in the near future to be listing on NASDAQ. Please be aware of the forward-looking statements.
So Sernova is a cell therapeutics company and what we are working on is treatment of high-maintenance, lifelong
Sernova Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 14, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers